The BioHealth Capital Region recently played host to a series of significant events that drew attention from the global biopharma community. Notably, several Israeli BioHealth companies, some traveling directly from Israel, participated in these events, underscoring the region's growing prominence, especially after being recognized by GEN as a Top 3 BioPharma Cluster in the United States. This remarkable participation was made possible with the dedicated efforts of Aisha Espey, Director of Commerce, Head of Science and Technology from the Embassy of Israel in Washington DC, and Andrea Yonah, Director of Business Development for the U.S. East Coast/Midwest at the U.S. Israel Binational Industrial R&D (BIRD) Foundation.
The BioHealth Capital Region Forum serves as the region's premier gathering for the biopharma sector, fostering collaborations and discussions that advance public health and economic outcomes. The Crab Trap, now in its 8th year, is a competition spotlighting entrepreneurs with transformative health solutions. The Investment Conference is a platform for companies and investors to create partnerships, featuring brief presentations highlighting BioHealth opportunities and innovations.
"I want to recognize the significance of these Israeli BioHealth companies participating in our events. Their presence not only showcases global breakthroughs but also emphasizes the value of the BioHealth Capital Region as a prime location for their U.S. offices," said Rich Bendis, President and CEO of BioHealth Innovation, Inc. (BHI). "We're immensely grateful to Aisha Espey and Andrea Yonah for their unwavering commitment and partnership in bringing these trailblazing companies to the forefront."
Israeli delegation:
Lf to Rt: Max Simonovsky, Andrea Yonah, BIRD, Soapy; Uzi Ron, EyeControl; Craig Hillman, GaitBetter; Aisha Espey,
Israel Economic & Trade Mission to the US, Embassy of Israel; NucleoTech; Chen Ben Dori, OffRa Health
Companies in Focus:
- EyeControl: EyeControl offers an AI-powered communication device that enables locked-in and ventilated patients to communicate using only their eye movements. This innovative solution provides an immediate voice to those who cannot speak, bridging the communication gap in critical care situations.
- Flometrica: Flometrica has developed a SmartCup & services that are able to replace the present processes & technologies with a new way of diagnosing the medical conditions that patients experience with urine flow.
- GaitBetter: GaitBetter is a digital neurotherapeutic platform specifically designed for gait rehabilitation, prevention of falls, and prediction of neurodegenerative diseases. Adding cognitive engagement to treadmill training provides a clinically validated motor-cognitive intervention that was proven significantly more effective than alternatives.
- NucleoTech: NucleoTech's solution is a drug delivery platform designed to overcome the Blood-Brain Barrier's (BBB) limitations, allowing for non-invasive, effective treatments to CNS disorders. This approach relies on Receptor-Mediated Transcytosis (RMT) utilizing Nanobody carriers.
- OffRa Health: OffRa Health is building an innovative, comprehensive platform utilizing artificial intelligence and personalized approaches to provide comprehensive healthcare solutions for at-risk populations.
- Soapy: Soapy’s revolutionary AI-powered, fully automated, and touchless hand hygiene solution, is comprised of he Soapy Pro hand hygiene station and Soapy Wisdom - a cloud compliance reporting system. It is the only clinically tested hand hygiene system that significantly improves adherence and quality.
EyeControl stood out as a competitor in the Crab Trap Competition. Additionally, EyeControl, OffRa Health, NucleoTech, and Soapy were chosen for 7-minute quick-pitches during the Investment Conference on September 21st, showcasing their innovations when they weren't engaged in meetings with investors.
The BioHealth Capital Region offers immense value to Israeli companies and to all international companies looking to establish their presence in the U.S. The region boasts access to renowned institutions like the NIH and FDA, strong academic partnerships, affordable office and lab spaces, and a deep talent pool, making it an attractive hub for biotech and pharma innovations.
For international companies aspiring to expand to the U.S., the BioHealth Capital Region presents unparalleled opportunities. Companies interested in exploring these opportunities and seeking assistance with their U.S. expansion are encouraged to contact BioHealth Innovation Inc. for partnership and support.